Trump’s opioid plan: drug companies could face ‘major litigation’
Some related stocks posted losses of several percentage points before the president’s announcement.
Tuesday, March 20, 2018
Trump’s opioid plan: drug companies could face ‘major litigation’
Trump’s opioid plan: drug companies could face ‘major litigation’
Some related stocks posted losses of several percentage points before the president’s announcement.
0 comments:
Post a Comment